Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-04-08
2008-04-08
Robinson, Hope (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C514S002600, C514S016700, C530S350000, C530S300000
Reexamination Certificate
active
07354903
ABSTRACT:
Short bioactive peptides containing phenylalanine, leucine, alanine, and lysine residues are disclosed. The peptides can be used in antibacterial, antifungal, anticancer, and other biological applications.
REFERENCES:
patent: 4355104 (1982-10-01), Hultmark et al.
patent: 4520016 (1985-05-01), Hultmark et al.
patent: 5561107 (1996-10-01), Jaynes et al.
patent: 5620954 (1997-04-01), Maloy
patent: 5717064 (1998-02-01), Julian et al.
patent: 5744445 (1998-04-01), Jaynes et al.
patent: 5789542 (1998-08-01), McLaughlin
patent: 5861478 (1999-01-01), Jaynes
patent: 5962410 (1999-10-01), Jaynes et al.
patent: 6001805 (1999-12-01), Jaynes et al.
patent: 6084156 (2000-07-01), Garbabino
patent: 6191110 (2001-02-01), Jaynes et al.
patent: 6255282 (2001-07-01), Jaynes
patent: 6303568 (2001-10-01), Haynes et al.
patent: 6331440 (2001-12-01), Nordstedt et al.
patent: 6348445 (2002-02-01), Kari et al.
patent: 6440935 (2002-08-01), Jaynes et al.
patent: 6559281 (2003-05-01), Jaynes
patent: 6566334 (2003-05-01), McLaughlin
patent: 6635740 (2003-10-01), Enright et al.
patent: 6958212 (2005-10-01), Hubbell et al.
patent: 1004595 (2000-05-01), None
patent: WO 96/03519 (1996-02-01), None
patent: WO 01/49834 (2001-07-01), None
Galvin, et al; “Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations.” Brit. Journ. Dermatology 139 (suppl 52) 1998:34-40.
Seffernick et al., J. Bacteriology, vol. 183, pp. 2405-2410, 2001.
Wells, Biochemistry, vol. 29, pp. 8509-8517, 1990.
Baghian et al., “An Amphipathic α-Helical Synthetic Peptide Analogue of Melittin Inhibits Herpes Simples Virus-1 (HSV-1)-Induced Cell Fusion and Virus Spread,”Peptides, 18(2):177-183 (1997).
Bessalle et al., “Structure-Function Studies of Amphiphilic Antibacterial Peptides,” J. Med. Chem., 1993, 36:1203-1209.
Blondelle et al., “Lipid-Induced Conformation and Lipid-Binding Properties of Cytolytic and Antimicrobial Peptides: Determination and Biological Specificity,”Biochimica et Biophysica Acta, 1462:89-108 (1999).
Dathe et al, “Structural Features of Helical Antimicrobial Peptides: Their Potential to Modulate Activity on Model Membranes and Biological Cells,”Biochimica et Biophysica Acta1462:71-87 (1999).
De Lucca et al., “Fungicidal Properties, Sterol Binding, and Proteolytic Resistance on the Synthetic Peptide D4E1,”Can. J. Microbiol, 44:514-520 (1998).
Dushay et al., “Two attacin Antibacterial Genes ofDrosophila melanogaster,” Gene, 246:49-57 (2000).
Ekengren et al., Drosophila Cecropin as an Antifungal Agent,Insect Biochemistry and Molecular Biology, 29:965-972 (1999).
Epand et al., “Diversity of Antimicrobial Peptides and Their Mechanisms of Action,”Biochimica et Biophysica Acta1462:11-28 (1999).
Friedrich et al., “Salt-Resistant Alpha-Helical Cationic Antimicrobial Peptides,”Antimicrobial Agents and Chemotherapy, pp. 1542-1548 (1999).
Giacometti et al., “Antimicrobial Activity of Polycationic Peptides,”Peptide, 20:1265-1273 (1999).
Giacometti et al., “In-Vitro Activity of Cationic Peptides Alone and in Combination with Clinically Used Antimicrobial Agents AgainstPseudomonas aeruginosa,” Journal of Antimicrobial Chemotherapy, 44:641-645 (1999).
Goraya et al., “Peptides with Antimicrobial Activity from Four Different Families Isolated from the Skins of the North American FrogsRana luteiventris, Rana berlandieriandRana pipiens,” Eur. J. Biochem, 267:894-900 (2000).
Hancock et al., “Cationic Peptides: A New Source of Antibiotics,”Tibtech, 16:82-88 (1998).
Hancock et al., “Peptide Antibiotics,”Antimicrobial Agents and Chemotherapy, pp. 1317-1323 (1999).
Hancock, “Host Defence (Cationic) Peptides. What is Their Future Clinical Potential?”,Drugs4:469-473 (1999).
Hancock, “Peptide Antibiotics,”Lancet, 349:418-422 (1997).
Hong et al., Structure and Organization of Hemolytic and Nonhemolytic Diastereomers of Antimicrobial Peptides in Membranes,Biochemistry, 38:16963-16973 (1999).
Hung et al., “Membrane Lysis by the Antibacterial Peptides on Cecropins B1 and B3: A Spin-Label Electron Spin Resonance Study on Phospholipid Bilayers,”Biophysical Journal, 77:3120-3233 (1999).
Jia et al., “Antimicrobial Peptides Protect Coho Salmon fromVibrio anguillarumInfections,”Applied and Environmental Microbiology, 66(5):1928-1932 (2000).
Juvvadi et al., “Structure-Activity Studies of Normal and Retro Pig Cecropin-Melittin Hybrids,”J. Peptide Res., 53:244-251 (1999).
Kondejewski et al, “Dissociation of Antimicrobial and Hemolytic Activities in the Cyclic Peptide Diastereomers by Systematic Alterations in Amphipathicity,”The Journal of Biological Chemistry, 274(19):13181-13192 (1999).
Lowenberger et al., Antimicrobial Activity Spectrum, cDNA Cloning, and mRNA Expression of a Newly Isolated Member of the Cecropin Family from the Mosquito VectorAedes aegypti, The Journal of Biological Chemistry, 274(29):20092-20097 (1999).
Martin et al., “Evaluation of the Effect of Peptidyl Membrane-Interactive Molecules of Avian Coccidia,”Parasitol Res., 85:331-336 (1999).
McInnes et al., “Development of the Structural Basis for Antimicrobial and Hemolytic Activities of Peptides Based on Gramicidin S and Design of Novel Analogs Using NMR Spectroscopy,”The Journal of Biological Chemistry, 275(19):14287-14294 (2000).
Oh et al., “Activities of Synthetic Hybrid Peptides Against Anaerobic Bacteria: Aspects of Methodology and Stability,”Antimicrobial Agents and Chemotherapy, pp. 68-72 (2000).
Oh et al., “Cationic Peptide Antimicrobials Induce Selective Transcription of micF and osmY inEscherichia coli,” Biochimica et Biophysica Acta, 1463:43-54 (2000).
Oh, J.E., et al., “Design, Synthesis and Characterization—(A Model Decapeptide),” J. Peptide Res., 1999, 54:129-136.
Osapay et la., “Formation and Characterization of a Single Trp-Trp Cross-Link in Indolicidin the Confers Protease Stability Without Altering Antimicrobial Activity,”The Journal of Biological Chemistry, 275(16):12017-12022 (2000).
Reed et al., Interleukin 2 Promoter/Enhancer Controlled Expression of a Synthetic Cecropin-Class Lytic Peptide in Transgenic Mice and Subsequent Resistance toBrucella abortus, Transgenic Research, 6:337-347 (1997).
Robertson et al., “Peptidyl Membrane-Interactive Molecules are Cytotoxic to Prostatic Cancer Cells in vitro,”World J. Urol., 16:405-409 (1998).
Rocca et al., “Simulation Studies of the Interaction of Antimicrobial Peptides and Lipid Bilayers,”Biochimica et Biophysica Acta, 1462:185-200 (1999).
Schwab et al., “In Vitro Activities of Designated Antimicrobial Peptides Against Multidrug-Resistant Cystic Fibrosis Pathogens,”Antimicrobial Agents and Chemotherapy, pp. 1435-1440 (1999).
Scott et al., “Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides,”Infection and Immunity, 67(4):2005-2009 (1999).
Scott et al., “Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein,”The Journal of Immunology, pp. 549-533 (2000).
Shin et al., “Effects of the Hinge Region of Cecropin A(1-8)-Magainin 2(1-12), a Synthetic Antimicrobial Peptide, on Liposomes; Barterial and Tumor Cells,”Biochimica et Biophysica Acta, 1463:209-218 (2000).
Shin et al., “Structure-Antibacterial, Antitumor and Hemolytic Activity Relationships of Cecropin A-magainin 2 and Cecropin A-Melittin Hybrid Peptides,”J. Peptide Res., 53:82-90 (1999).
Silvestro, et al. “Antibacterial and Antimembrane Activities of Cecropin A inEscherichia coli”, Antimicrobial Agents and Chemotherapy, pp. 602-607 (2000).
Wang et al, “The Effect of pH on the Structure, Binding and Model Membrane Lysis by Cecropin B and Analogs,”Biochimica
Helix Biomedix, Inc.
Howrey LLP
Robinson Hope
LandOfFree
Cosmetic compositions containing short bioactive peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cosmetic compositions containing short bioactive peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cosmetic compositions containing short bioactive peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2762799